Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
CCR5-blocking antibody leads to long-term HIV suppression
In an ongoing trial of people on failing antiretroviral regimens, the injectable PRO 140 reduced viral load considerably.
One injection of the cloned antibody significantly reduced participants’ viral load in a recent advanced trial.
New questions about Charlie Sheen’s infamous visits to The Dr. Oz show.
A weekly injection of an HIV antibody boasted a 98 percent success rate among participants in a small trial.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.